nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimetrexate—DHFR—Metabolism of folate and pterines—MTHFR—atherosclerosis	0.0292	0.0809	CbGpPWpGaD
Trimetrexate—Hepatotoxicity—Niacin—atherosclerosis	0.0271	0.0425	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Lovastatin—atherosclerosis	0.0244	0.0382	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Ezetimibe—atherosclerosis	0.0239	0.0375	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Simvastatin—atherosclerosis	0.0228	0.0357	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Pravastatin—atherosclerosis	0.0206	0.0323	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.0204	0.0319	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.02	0.0313	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.019	0.0298	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.0172	0.0269	CcSEcCtD
Trimetrexate—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—NOS3—atherosclerosis	0.0162	0.0448	CbGpPWpGaD
Trimetrexate—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.0156	0.0245	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.0153	0.024	CcSEcCtD
Trimetrexate—DHFR—Metabolism of nitric oxide—CAV1—atherosclerosis	0.0148	0.041	CbGpPWpGaD
Trimetrexate—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.0132	0.0207	CcSEcCtD
Trimetrexate—DHFR—One Carbon Metabolism—MTHFR—atherosclerosis	0.0118	0.0326	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism of nitric oxide—NOS3—atherosclerosis	0.0112	0.031	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—MPO—atherosclerosis	0.0107	0.0297	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—LDLR—atherosclerosis	0.0107	0.0295	CbGpPWpGaD
Trimetrexate—DHFR—Trans-sulfuration and one carbon metabolism—MTHFR—atherosclerosis	0.0106	0.0293	CbGpPWpGaD
Trimetrexate—Confusional state—Rosuvastatin—atherosclerosis	0.0104	0.0162	CcSEcCtD
Trimetrexate—DHFR—Fluoropyrimidine Activity—MTHFR—atherosclerosis	0.0103	0.0286	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—F7—atherosclerosis	0.0103	0.0285	CbGpPWpGaD
Trimetrexate—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.0101	0.0157	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—SCARB1—atherosclerosis	0.00997	0.0276	CbGpPWpGaD
Trimetrexate—Anaemia—Ezetimibe—atherosclerosis	0.00967	0.0151	CcSEcCtD
Trimetrexate—Anaemia—Simvastatin—atherosclerosis	0.00922	0.0144	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—PLAT—atherosclerosis	0.00918	0.0254	CbGpPWpGaD
Trimetrexate—Confusional state—Lovastatin—atherosclerosis	0.00878	0.0137	CcSEcCtD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—atherosclerosis	0.00871	0.0241	CbGpPWpGaD
Trimetrexate—Confusional state—Ezetimibe—atherosclerosis	0.00861	0.0135	CcSEcCtD
Trimetrexate—Thrombocytopenia—Lovastatin—atherosclerosis	0.00852	0.0133	CcSEcCtD
Trimetrexate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00846	0.0132	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—ABCA1—atherosclerosis	0.00839	0.0232	CbGpPWpGaD
Trimetrexate—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00836	0.0131	CcSEcCtD
Trimetrexate—Anaemia—Pravastatin—atherosclerosis	0.00834	0.013	CcSEcCtD
Trimetrexate—Confusional state—Simvastatin—atherosclerosis	0.00821	0.0128	CcSEcCtD
Trimetrexate—Thrombocytopenia—Simvastatin—atherosclerosis	0.00797	0.0125	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—PLG—atherosclerosis	0.0078	0.0216	CbGpPWpGaD
Trimetrexate—Fatigue—Lovastatin—atherosclerosis	0.0075	0.0117	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—SOD1—atherosclerosis	0.00748	0.0207	CbGpPWpGaD
Trimetrexate—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—atherosclerosis	0.00744	0.0206	CbGpPWpGaD
Trimetrexate—Confusional state—Pravastatin—atherosclerosis	0.00742	0.0116	CcSEcCtD
Trimetrexate—Asthenia—Rosuvastatin—atherosclerosis	0.00737	0.0115	CcSEcCtD
Trimetrexate—Fatigue—Ezetimibe—atherosclerosis	0.00736	0.0115	CcSEcCtD
Trimetrexate—Pruritus—Rosuvastatin—atherosclerosis	0.00727	0.0114	CcSEcCtD
Trimetrexate—Thrombocytopenia—Pravastatin—atherosclerosis	0.00721	0.0113	CcSEcCtD
Trimetrexate—Feeling abnormal—Lovastatin—atherosclerosis	0.00717	0.0112	CcSEcCtD
Trimetrexate—Feeling abnormal—Ezetimibe—atherosclerosis	0.00703	0.011	CcSEcCtD
Trimetrexate—Fatigue—Simvastatin—atherosclerosis	0.00702	0.011	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—APOB—atherosclerosis	0.0069	0.0191	CbGpPWpGaD
Trimetrexate—Body temperature increased—Lovastatin—atherosclerosis	0.00688	0.0108	CcSEcCtD
Trimetrexate—Body temperature increased—Ezetimibe—atherosclerosis	0.00675	0.0106	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—SOD2—atherosclerosis	0.00674	0.0187	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Simvastatin—atherosclerosis	0.00671	0.0105	CcSEcCtD
Trimetrexate—Rash—Rosuvastatin—atherosclerosis	0.00648	0.0101	CcSEcCtD
Trimetrexate—Dermatitis—Rosuvastatin—atherosclerosis	0.00647	0.0101	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—SIRT1—atherosclerosis	0.00646	0.0179	CbGpPWpGaD
Trimetrexate—Body temperature increased—Simvastatin—atherosclerosis	0.00644	0.0101	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—GPX1—atherosclerosis	0.00643	0.0178	CbGpPWpGaD
Trimetrexate—Fatigue—Pravastatin—atherosclerosis	0.00635	0.00993	CcSEcCtD
Trimetrexate—Asthenia—Lovastatin—atherosclerosis	0.00624	0.00977	CcSEcCtD
Trimetrexate—Pruritus—Lovastatin—atherosclerosis	0.00616	0.00964	CcSEcCtD
Trimetrexate—Asthenia—Ezetimibe—atherosclerosis	0.00612	0.00959	CcSEcCtD
Trimetrexate—Nausea—Rosuvastatin—atherosclerosis	0.0061	0.00955	CcSEcCtD
Trimetrexate—Feeling abnormal—Pravastatin—atherosclerosis	0.00607	0.00949	CcSEcCtD
Trimetrexate—Pruritus—Ezetimibe—atherosclerosis	0.00604	0.00945	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—MTHFR—atherosclerosis	0.00593	0.0164	CbGpPWpGaD
Trimetrexate—Body temperature increased—Niacin—atherosclerosis	0.00591	0.00925	CcSEcCtD
Trimetrexate—Asthenia—Simvastatin—atherosclerosis	0.00584	0.00914	CcSEcCtD
Trimetrexate—Body temperature increased—Pravastatin—atherosclerosis	0.00582	0.00911	CcSEcCtD
Trimetrexate—Pruritus—Simvastatin—atherosclerosis	0.00576	0.00901	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—CRP—atherosclerosis	0.00564	0.0156	CbGpPWpGaD
Trimetrexate—Vomiting—Lovastatin—atherosclerosis	0.00553	0.00866	CcSEcCtD
Trimetrexate—Rash—Lovastatin—atherosclerosis	0.00549	0.00859	CcSEcCtD
Trimetrexate—Dermatitis—Lovastatin—atherosclerosis	0.00548	0.00858	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—APOA1—atherosclerosis	0.00546	0.0151	CbGpPWpGaD
Trimetrexate—Vomiting—Ezetimibe—atherosclerosis	0.00543	0.0085	CcSEcCtD
Trimetrexate—Rash—Ezetimibe—atherosclerosis	0.00538	0.00842	CcSEcCtD
Trimetrexate—Dermatitis—Ezetimibe—atherosclerosis	0.00538	0.00842	CcSEcCtD
Trimetrexate—Asthenia—Niacin—atherosclerosis	0.00536	0.00839	CcSEcCtD
Trimetrexate—Pruritus—Niacin—atherosclerosis	0.00529	0.00828	CcSEcCtD
Trimetrexate—Asthenia—Pravastatin—atherosclerosis	0.00528	0.00826	CcSEcCtD
Trimetrexate—Pruritus—Pravastatin—atherosclerosis	0.00521	0.00815	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—F2—atherosclerosis	0.00521	0.0144	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—ICAM1—atherosclerosis	0.00519	0.0144	CbGpPWpGaD
Trimetrexate—Vomiting—Simvastatin—atherosclerosis	0.00518	0.0081	CcSEcCtD
Trimetrexate—Nausea—Lovastatin—atherosclerosis	0.00517	0.00809	CcSEcCtD
Trimetrexate—DHFR—Metabolism of nitric oxide—AKT1—atherosclerosis	0.00515	0.0143	CbGpPWpGaD
Trimetrexate—Rash—Simvastatin—atherosclerosis	0.00513	0.00803	CcSEcCtD
Trimetrexate—Dermatitis—Simvastatin—atherosclerosis	0.00513	0.00803	CcSEcCtD
Trimetrexate—Nausea—Ezetimibe—atherosclerosis	0.00507	0.00794	CcSEcCtD
Trimetrexate—Nausea—Simvastatin—atherosclerosis	0.00484	0.00757	CcSEcCtD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—atherosclerosis	0.00475	0.0132	CbGpPWpGaD
Trimetrexate—Vomiting—Niacin—atherosclerosis	0.00475	0.00744	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—INS—atherosclerosis	0.00472	0.0131	CbGpPWpGaD
Trimetrexate—Rash—Niacin—atherosclerosis	0.00471	0.00738	CcSEcCtD
Trimetrexate—Dermatitis—Niacin—atherosclerosis	0.00471	0.00737	CcSEcCtD
Trimetrexate—Vomiting—Pravastatin—atherosclerosis	0.00468	0.00732	CcSEcCtD
Trimetrexate—Rash—Pravastatin—atherosclerosis	0.00464	0.00726	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—CCL2—atherosclerosis	0.00464	0.0129	CbGpPWpGaD
Trimetrexate—Dermatitis—Pravastatin—atherosclerosis	0.00464	0.00726	CcSEcCtD
Trimetrexate—Nausea—Niacin—atherosclerosis	0.00444	0.00695	CcSEcCtD
Trimetrexate—Nausea—Pravastatin—atherosclerosis	0.00437	0.00684	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—SERPINE1—atherosclerosis	0.00433	0.012	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—ALB—atherosclerosis	0.00432	0.012	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—SERPINE1—atherosclerosis	0.004	0.0111	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—IFNG—atherosclerosis	0.00395	0.0109	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—IL1B—atherosclerosis	0.00352	0.00975	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—NFKB1—atherosclerosis	0.00328	0.00909	CbGpPWpGaD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—atherosclerosis	0.00303	0.0084	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—TNF—atherosclerosis	0.00255	0.00707	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—LDLRAP1—atherosclerosis	0.00221	0.00612	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PLTP—atherosclerosis	0.00208	0.00576	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—IL6—atherosclerosis	0.00206	0.00571	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCG8—atherosclerosis	0.0018	0.00499	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—LTA4H—atherosclerosis	0.0018	0.00499	CbGpPWpGaD
Trimetrexate—DHFR—Disease—APOA4—atherosclerosis	0.00157	0.00435	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCG1—atherosclerosis	0.00142	0.00395	CbGpPWpGaD
Trimetrexate—DHFR—Disease—APOA2—atherosclerosis	0.00135	0.00374	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—LCAT—atherosclerosis	0.00134	0.00371	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—FABP4—atherosclerosis	0.00134	0.00371	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—APOA4—atherosclerosis	0.00131	0.00364	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP7A1—atherosclerosis	0.00129	0.00358	CbGpPWpGaD
Trimetrexate—DHFR—Disease—BGN—atherosclerosis	0.00125	0.00346	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP27A1—atherosclerosis	0.00119	0.00331	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PLA2G2A—atherosclerosis	0.00113	0.00313	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALOX5AP—atherosclerosis	0.00113	0.00313	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALOX15—atherosclerosis	0.00113	0.00313	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—APOA2—atherosclerosis	0.00113	0.00313	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCG5—atherosclerosis	0.00112	0.0031	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CST3—atherosclerosis	0.00109	0.00301	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—LPA—atherosclerosis	0.00108	0.00299	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—BGN—atherosclerosis	0.00105	0.0029	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—APOA5—atherosclerosis	0.00104	0.00287	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NAMPT—atherosclerosis	0.00103	0.00285	CbGpPWpGaD
Trimetrexate—DHFR—Disease—APOC3—atherosclerosis	0.00102	0.00282	CbGpPWpGaD
Trimetrexate—DHFR—Disease—LDLR—atherosclerosis	0.00101	0.0028	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PLA2G1B—atherosclerosis	0.000996	0.00276	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HSPA1B—atherosclerosis	0.000977	0.00271	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALOX5—atherosclerosis	0.000962	0.00267	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NCF1—atherosclerosis	0.000946	0.00262	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CYBA—atherosclerosis	0.00089	0.00246	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PARP1—atherosclerosis	0.000871	0.00241	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NAMPT—atherosclerosis	0.000863	0.00239	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—LIPC—atherosclerosis	0.000858	0.00238	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—APOC3—atherosclerosis	0.000852	0.00236	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—LDLR—atherosclerosis	0.000847	0.00235	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CETP—atherosclerosis	0.000828	0.00229	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SCARB1—atherosclerosis	0.000793	0.00219	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HMGCR—atherosclerosis	0.000748	0.00207	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ABCA1—atherosclerosis	0.000667	0.00185	CbGpPWpGaD
Trimetrexate—DHFR—Disease—APOB—atherosclerosis	0.000655	0.00181	CbGpPWpGaD
Trimetrexate—DHFR—Disease—LPL—atherosclerosis	0.000625	0.00173	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PRKCG—atherosclerosis	0.000608	0.00168	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—MAPK3—atherosclerosis	0.000583	0.00162	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HMOX1—atherosclerosis	0.000572	0.00159	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MTHFR—atherosclerosis	0.000563	0.00156	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—APOB—atherosclerosis	0.000548	0.00152	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PDGFB—atherosclerosis	0.000548	0.00152	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTM1—atherosclerosis	0.000533	0.00148	CbGpPWpGaD
Trimetrexate—DHFR—Disease—APOE—atherosclerosis	0.000524	0.00145	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—LPL—atherosclerosis	0.000523	0.00145	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MAPK3—atherosclerosis	0.000521	0.00144	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CAV1—atherosclerosis	0.000519	0.00144	CbGpPWpGaD
Trimetrexate—DHFR—Disease—APOA1—atherosclerosis	0.000518	0.00143	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GPX1—atherosclerosis	0.000511	0.00141	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CD36—atherosclerosis	0.000497	0.00138	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NOS2—atherosclerosis	0.000488	0.00135	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—MTHFR—atherosclerosis	0.000471	0.00131	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PPARA—atherosclerosis	0.000462	0.00128	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—AGT—atherosclerosis	0.000448	0.00124	CbGpPWpGaD
Trimetrexate—DHFR—Disease—INS—atherosclerosis	0.000448	0.00124	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—APOE—atherosclerosis	0.000439	0.00122	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CAV1—atherosclerosis	0.000435	0.0012	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—APOA1—atherosclerosis	0.000434	0.0012	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SERPINE1—atherosclerosis	0.000411	0.00114	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PIK3CG—atherosclerosis	0.000396	0.0011	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NOS3—atherosclerosis	0.000393	0.00109	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PPARG—atherosclerosis	0.000382	0.00106	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—INS—atherosclerosis	0.000375	0.00104	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PTGS2—atherosclerosis	0.000359	0.000994	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALB—atherosclerosis	0.000344	0.000952	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NOS3—atherosclerosis	0.000329	0.00091	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PTGS2—atherosclerosis	0.000301	0.000833	CbGpPWpGaD
Trimetrexate—DHFR—Disease—STAT3—atherosclerosis	0.00028	0.000775	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MAPK3—atherosclerosis	0.000268	0.000741	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TGFB1—atherosclerosis	0.00026	0.000719	CbGpPWpGaD
Trimetrexate—DHFR—Disease—IL6—atherosclerosis	0.000196	0.000542	CbGpPWpGaD
Trimetrexate—DHFR—Disease—AKT1—atherosclerosis	0.00018	0.0005	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—AKT1—atherosclerosis	0.000151	0.000418	CbGpPWpGaD
